Clinical Trials Directory

Trials / Completed

CompletedNCT02103985

A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants

A Randomized, Open-Label, Two-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Male and Female Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the effect of food on the bioavailability of a single oral dose of JNJ-39823277 and its active metabolites.

Detailed description

This is a randomized (the study medication is assigned by chance), open-label (all people know the identity of the intervention), single-center, 2 treatment-sequence, and crossover study (method used to switch participants from one treatment arm to another in a clinical study). The study consist of 3 phases: a screening phase (within 21 days before medication administration), a 2-period open-label treatment phase, during which each participant will receive 1 of 2 open-label treatment sequences, and the end-of-study or withdrawal assessments (within 7-11 days after the last dose of the study medication). Participants will be randomly assigned to 1 of 2 treatment-sequences: Treatment Sequence AB (dosing in fed \[with high fat diet\] condition followed by dosing in fasted \[without food\] condition) or Treatment Sequence BA (dosing in fasted condition followed by dosing in fed condition). Study medication administrations will be separated by a washout period (period when receiving no treatment) of 7 to 14 days. The study duration for each participant will be approximately 6 weeks.

Conditions

Interventions

TypeNameDescription
DRUGJNJ-39823277Participants will receive 100 mg of JNJ-39823277 tablet orally (by mouth) as a single dose.

Timeline

Start date
2009-05-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2014-04-04
Last updated
2014-06-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02103985. Inclusion in this directory is not an endorsement.